Reuters: Health
British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for Lupuzor, a first-in-class treatment for auto-immune disease Lupus, with U.S. company Avion Pharmaceuticals.
ImmuPharma licenses lupus drug Lupuzor to Avion in the United States
ImmuPharma licenses lupus drug Lupuzor to Avion in the United States
Reuters: Health
British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for Lupuzor, a first-in-class treatment for auto-immune disease Lupus, with U.S. company Avion Pharmaceuticals.
Reuters: Health
British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for Lupuzor, a first-in-class treatment for auto-immune disease Lupus, with U.S. company Avion Pharmaceuticals.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment